[Federal Register: January 11, 2002 (Volume 67, Number 8)]
[Notices]               
[Page 1489-1490]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11ja02-68]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C.,

[[Page 1490]]

as amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Signal Transduction in Oscogenesis.
    Date: January 11, 2002.
    Time: 10:00 AM to 2:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: 6116 Executive Blvd., Rockville, MD 20892, (Telephone 
Conference Call).
    Contact Person: Virginia P. Wray, PhD, Scientific Review 
Administrator, National Cancer Institute, DEA GRB, 6116 Executive 
Boulevard, Room 8125, Rockville, MD 20895-7405, 301-496-9236, 
vw8z@nih.gov
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: January 4, 2002.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-746 Filed 1-10-02; 8:45 am]
BILLING CODE 4140-01-M